Calcineurin inhibitor and eltrombopag combination for acquired aplastic anemia: results from a large national database
database[Title] 2025-12-10
Summary:
CONCLUSION: These findings underscore the efficacy and feasibility of double therapy with CNI and EPAG for adults with AA in the real-world setting, offering an alternative for patients when triple therapy is not possible.